Citizens JMP reiterates Market Outperform rating on Chewy stock

Published 11/09/2025, 09:56
Citizens JMP reiterates Market Outperform rating on Chewy stock

Investing.com - Citizens JMP has reiterated its Market Outperform rating on Chewy Inc. (NYSE:CHWY) with a price target of $48.00, representing significant upside from the current price of $35.11. According to InvestingPro data, five analysts have recently revised their earnings estimates upward for the upcoming period.

The firm cited Chewy’s increasing service stickiness as a key factor, noting that Autoship penetration grew nearly 5 points year-over-year, while the Chewy+ subscription program is showing strong early results in driving customer engagement. This growth contributes to the company’s solid 9.17% year-over-year revenue increase.

Despite acknowledging that Chewy’s profitability progress could be faster, Citizens JMP has raised its top-line estimates for the company while maintaining they remain conservative.

The firm identified several potential catalysts for future growth, including Chewy’s Vet Clinics and continued progress with health and pharmacy offerings, stating the company has multiple levers to drive business upside.

Citizens JMP expects Chewy to continue gaining market share while expanding margins with consistent 15% incremental margins, and recommended investors purchase shares on any weakness.

In other recent news, Chewy Inc . reported its second-quarter earnings for 2025, demonstrating steady growth in both revenue and earnings per share (EPS), aligning with analyst expectations. The company achieved an EPS of $0.33, which was in line with forecasts, while revenue slightly surpassed predictions, reaching $3.1 billion. William Blair reiterated an Outperform rating for Chewy following these results, highlighting a modest upside in sales, gross margin, and adjusted EBITDA. The firm also noted the addition of 150,000 active customers, which exceeded sell-side consensus expectations but fell short of some buy-side projections.

Meanwhile, BNP Paribas Exane adjusted its price target for Chewy to $34.00 from $38.00, maintaining a Neutral rating. The adjustment was attributed to concerns about market expectations being set too high, which had previously led to a downgrade in December. These developments reflect varying analyst perspectives on Chewy’s performance and future potential. Investors are closely watching how the company navigates market conditions and adjusts its strategies moving forward.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.